Cabimer

Name

Cabimer

Legal name

Centro Andaluz de Biología Molecular y Medicina Regenerativa

Website

https://cabimer.es

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Biomedical Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGANAE

Transcriptomics & Gene Expression Profiling Services

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)

SECONDARYHLAAAGAE

Cell & Tissue Banking (biobanking, cord blood/tissue)

Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering

Keywords

• Molecular biology research
• Regenerative medicine research
• Biomedical research center
• Genomics core facility
• Proteomics research services

Headquarters

HQ city

Sevilla

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Distribution channels1 record

Marketing channels5 records

Core offering

Cabimer is a public biomedical research center that conducts molecular biology and regenerative medicine research through three main research lines (Genome Biology, Cell Dynamics and Signaling, and Integrative Pathophysiology and Therapies). It provides shared scientific infrastructure through nine specialized core facilities covering Genomics, Proteomics, Bioinformatics, Microscopy, Cell Culture, Flow Cytometry, Model Organism studies, Biological Resources, and Histology, supporting both internal and external researchers.

Product overview

Cabimer (Centro Andaluz de Biología Molecular y Medicina Regenerativa) is a biomedical research center in Seville, Spain. The institution operates as a research organization organized around three main research lines: Genome Biology, Cell Dynamics and Signaling, and Integrative Pathophysiology and Therapies. It provides research services through its Core Facilities, which include Genomics, Proteomics, Bioinformatics, Microscopy, Cell Culture, Flow Cytometry, Model Organism, Biological Resources, and Histology. Cabimer does not offer commercial software products or services.

Differentiator

Problem solved

Functional benefit

Products and services

• Genome Biology Research Research program focused on understanding genome structure, function, and mechanisms of genome stability and instability, including DNA damage response.
• Cell Dynamics and Signaling Research Research program investigating cellular signaling pathways and dynamic processes in biological systems.
• Integrative Pathophysiology and Therapies Research Research program aimed at understanding disease mechanisms and developing therapeutic approaches through integrative analysis.
• Core Facilities Services Shared scientific infrastructure providing specialized research services including Genomics, Proteomics, Bioinformatics, Microscopy, Cell Culture, Flow Cytometry, Model Organism, Biological Resources, and Histology to support internal and external researchers.

Quantifiable outcome

• Publications in high-impact journals including J Exp Clin Cancer Res, Surv Ophthalmol, Science Advances, and Proc Natl Acad Sci U S A

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Four partnerships are on record, tiered core.

• Junta de AndalucíacoreStrategic or Co-development PartnerRegional government of Andalusia providing institutional support and funding for the research center. One of the founding entities of Cabimer.
• CSIC (Consejo Superior de Investigaciones Científicas)coreStrategic or Co-development PartnerSpain's largest public research institution, serving as a founding partner of Cabimer and providing research framework and scientific oversight.
• University of SevillecoreStrategic or Co-development PartnerMajor public university in Seville, contributing academic expertise and researchers to the center's research programs.
• Pablo Olavide UniversitycoreStrategic or Co-development PartnerPublic university in Seville participating as a founding partner, providing academic and research collaboration.

Recent moves4 records

Expansion highlights4 records

Regional players

• Centro de Regulación Genómica (CRG) - already listed: Already included above as direct peer; this placeholder removed to avoid duplicates.

Broad incumbents

• Salk Institute for Biological Studies: California-based nonprofit biological research institute with research in molecular biology, genetics, and neuroscience. Comparable in nonprofit research-center operating model with multi-line basic science agenda.
• European Molecular Biology Laboratory (EMBL): Pan-European intergovernmental research organization with units across multiple countries operating in molecular biology and life sciences. Larger and more globally distributed, but highly comparable in core facilities and research scope.
• Broad Institute of MIT and Harvard: Major US genomics and biomedical research institute with strong capabilities in genomics, proteomics, and bioinformatics. Operates at much larger scale but directly comparable core facility portfolio.
• Francis Crick Institute: Large UK biomedical discovery institute with multiple research lines and extensive core facilities, funded through a consortium of major research funders. Comparable scale and consortium governance to Cabimer.

Direct peers

• Centro Nacional de Investigaciones Oncológicas (CNIO): Spain's premier cancer research center in Madrid, also operating as a public consortium with multidisciplinary research lines and core facilities. Directly comparable to Cabimer in mission, governance model (public funding, multiple research lines), and Spanish biomedical research context.
• Centre for Genomic Regulation (CRG): Barcelona-based biomedical research institute with core facilities in genomics, proteomics, bioinformatics, and advanced microscopy. Highly comparable to Cabimer in life sciences focus and core-facility-driven research model.
• Centro de Biología Molecular Severo Ochoa (CBMSO): Madrid-based CSIC-Universidad Autónoma molecular biology center focused on genome biology, cell signaling, and molecular medicine. Directly comparable to Cabimer in research lines and Spanish public-research-center operating model.
• IRB Barcelona (Institute for Research in Biomedicine): Barcelona-based biomedical research center with research lines in cancer, cell biology, and computational biology, plus shared core facilities. Closely comparable in scale, mission, and Catalan/Spanish regional research ecosystem.
• Institute of Molecular Biology of Barcelona (IBMB-CSIC): CSIC-affiliated molecular biology research center in Barcelona with overlapping research areas in genome biology and cellular signaling. Shares the CSIC institutional parent and similar basic-research orientation.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/cabimer

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cabimer